A treatment algorithm for Hepatic Angiomyolipomas: a long-term follow-up study and a systematic review

A treatment algorithm for Hepatic Angiomyolipomas: a long-term follow-up study and a systematic review - Managment of Hepatic Angiomyolipoma's

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44998

Enrollment

Registered

2016-07-07

Start date

2016-07-07

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign liver tumor Mesenchymal tumor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Eighteen years or older; Diagnosis of HAML either by MRI, biopsy or after tumor resection; Previous MRI scan with baseline characteristics for patients who received a non-surgical treatment.

Exclusion criteria

Exclusion criteria: Contrast allergy; MRI contraindication (e.g. pacemaker, metal) Renal failure.

Design outcomes

Primary

Measure	Time frame
Number of recurrences, growth (size of tumor) or new HAML tumors.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results